تحت رعاية سمو الشـــيخ حــمــدان بن راشـــد آل مــكـتوم، نائب حاكم دبي، وزير المالية، رئيس هيئة الصحة بدبي

Under the patronage of His Highness Sheikh Hamdan bin Rashid Al Maktoum, Deputy Ruler of Dubai, Minister of Finance and President of the Dubai Health Authority

Dubai International Pharmaceutical & Technology Conference & Exhibition DUPHAT Tech is part of DUPHAT

25 - 27 Feb 2020

DICC, Dubai
#DUPHAT#DUPHATTECH

Blog

Home - Archive by category: Blog

GENE THERAPY – A Boon for Retinitis Pigmentosa

GENE THERAPY – A Boon for Retinitis Pigmentosa
  • Date: Dec 08, 2019
  • Category:
Retinitis Pigmentosa (RP), an inherited disorder, although roughly affects 1 in 4,000 people, worldwide, results in the loss of peripheral vision in people suffering from this disease. While more than 200 causative mutations of RP have been previously discovered in more than 50 different genes, the molecular defect is distinguishable in just about half of […]
Read More

Multiple Myeloma ~ a perky dynamism

Multiple Myeloma
  • Date: Dec 02, 2019
  • Category:
The global Myeloma incidence is on the hike for the past three decades. The trends vary with different geographies. However, the low- and middle- income countries reported a consistent increase from 1990 to 2016 in Myeloma incidence and deaths due to Myeloma. This can be attributed to the lack of standard healthcare facilities in counties […]
Read More

Healthcare Burden and subsequent advances in the Healthcare Sector of UAE

Healthcare Burden
  • Date: Nov 19, 2019
  • Category:
The United Arab Emirates is ranked among one of the most developed countries in the world. According to a survey by the World Bank, the GDP of the UAE reached all-time high to USD 414.18 Billion last year, an increase of around USD 399.458 Billion from USD 14.721 Billion in the year 1975. The consistent […]
Read More

The Biosimilars scenario in the MENA Region

The Biosimilars scenario in the MENA Region
  • Date: Oct 22, 2019
  • Category:
Biosimilars, a cost-effective alternative to expensive biologics, have emerged to become a viable solution to the patient access barrier which impacted earlier in case of biologics. Biosimilars are increasingly becoming popular for treating a wide range of life-threatening diseases and represent a rapidly expanding segment of pharmaceutical industry. As the name suggests, Biosimilars are therapeutic […]
Read More

Pompe Disease – Rare but still Matters

Pompe Disease – Rare but still Matters
  • Date: Oct 02, 2019
  • Category:
Pompe Diseases are usually characterized by a deficiency of an enzyme called acid alfa glucosidase (GAA). The enzyme helps by breaking down complex sugars in the body which, when in deficiency causes Pompe disease. The disease is a rare disorder with a current worldwide prevalence of 1 in 5,000 to 10,000 people. Global burden aside, […]
Read More